Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Richardson who wrote (126)	3/10/2000 12:49:00 PM
From: tuck	Read Replies (3) of 1833

Richard, This is an interesting situation. Three things get my attention with this one: 1) Carl owns 25% of the stock but has ties with nearly half the BOD. Not sure what the implications of that are. 2) Company 10-K mentions other competitors doing one thing or another with yeast-based genomics, but doesn't choose to enlighten us as to who those competitors might be. Do you know of any? I gather management believes Cadus is the only one with an entire platform technology, a complete drug discovery system, based on yeast. 3) How big a deal is this litigation, anyhow? Seems to me they are close to working around the patented technology problem. If they win the dispute, they can sue for the damages that arose from being jammed up like this. Seems to me the worst is priced in, but neither will the stock see double digits until a) the patent dispute is resolved and Cadus either wins or licenses, or b) Cadus announces they can do the readout another way. Interested in your thoughts about the above. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next